https://www.selleckchem.com/pr....oducts/2-3-butanedio
Acute complications, adverse events and satisfaction survey were assessed. The study included 31 patients with a mean of 13.49±2.42 years of age and with T1DM of 7.0±3.67 years of onset. The use of faster aspart was associated with lower time in hyperglycaemia 180mg/dL (25.8±11.3 vs. 22.4±9.5; p=0.011) and 250mg/dL (5.2±4.9 vs. 4.0±3.6; p=0.04), lower AUC 180mg/dL (10.8±6.5 vs. 9.3±6.1; p=0.03), and increased time in range (71.4±10.0 vs. 74.3±9.2; p=0.03). No significant changes in hypoglycaemia, HbA1c, in
Like
Comment
Share
